Literature DB >> 27937043

Mapping Trachoma in the Solomon Islands: Results of Three Baseline Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project.

Oliver Sokana1, Colin Macleod2,3, Kelvin Jack1, Robert Butcher2, Michael Marks2,4, Rebecca Willis5, Brian K Chu5, Claude Posala1, Anthony W Solomon2.   

Abstract

PURPOSE: We sought to complete the baseline trachoma map of the Solomon Islands by establishing prevalences of active trachoma and trichiasis in the provinces of Choiseul, Western, Rennell-Bellona, and Temotu.
METHODS: Using the standardized methodology developed for the Global Trachoma Mapping Project, we conducted cross-sectional community-based surveys from September to November 2013. Choiseul and Western provinces were each mapped as separate evaluation units (EUs); Rennell-Bellona and Temotu were combined to form a third EU.
RESULTS: A total of 9819 individuals were sampled for inclusion, with 9224 (93.3%) consenting to examination, of whom 4587 (46.3%) were female. Survey teams visited 82 villages, and surveyed 2448 households. Two EUs had prevalences of trachomatous inflammation - follicular (TF) in 1-9-year-olds over the 10% threshold at which WHO recommends mass distribution of azithromycin for at least 3 years (Western 20.4%, 95% confidence interval, CI 15.6-26.3%; Rennell-Bellona/Temotu 22.0%, 95% CI 18.5-26.0%). Choiseul had a TF prevalence of 6.1% (95% CI 4.1-8.6%), and met the criterion for a single round of mass antibiotic distribution before re-survey. The adjusted prevalences of trichiasis in those aged 15+ years were 0.0% (95% CI 0.0-0.2%) in Choiseul, 0.16% (95% CI 0.0-0.5%) in Western, and 0.10% (95% CI 0-0.3%) in Rennell-Bellona/Temotu provinces. All three EUs require implementation of the facial cleanliness and environmental improvement components of the trachoma elimination strategy.
CONCLUSION: Active trachoma is prevalent in the Solomon Islands. However, there is little evidence of the blinding complications of trachoma being a public health problem there. Further research into the explanation for this phenomenon is warranted.

Entities:  

Keywords:  Chlamydia trachomatis; Pacific; Solomon Islands; prevalence; survey; trachoma

Mesh:

Year:  2016        PMID: 27937043      PMCID: PMC5706973          DOI: 10.1080/09286586.2016.1238946

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


Introduction

The World Health Organization (WHO) estimates that more than 50 countries are endemic for trachoma, the most common infectious cause of blindness worldwide, responsible for visual impairment in an estimated 1.9 million people. In endemic communities, Chlamydia trachomatis serotypes A–C circulate among young children causing self-limiting conjunctival infections that decrease in duration with age. Trachomatous inflammation – follicular (TF) and trachomatous inflammation – intense (TI) are clinical manifestations of infection. Repeat inflammatory episodes may lead to accumulation of scar tissue, which can distort the eyelids and cause eyelashes to abrade the eye; when this occurs, it is known as trachomatous trichiasis (TT). This may lead to corneal opacification and blindness in severe cases. Several systems have been used to describe this complex, multistage process, however, a simplified grading system is the public health tool of choice for describing trachoma phenotypes. To eliminate trachoma, the WHO have endorsed the SAFE strategy (surgery, mass antibiotic treatment, promotion of facial cleanliness and environmental improvement), implemented in a stratified manner based on the population-level prevalence of clinical signs of disease. Trachoma is considered to be a public health problem if the prevalence of unmanaged TT is >0.2% of the population aged 15 years and older, or if the prevalence of TF is ≥5% in those aged 1–9 years. , The Solomon Islands is an archipelago of almost 1000 volcanic islands and coral atolls, with a population of approximately 520,000 inhabitants, spread over 28,400km2 of the South Pacific Ocean and the Solomon Sea. A number of small, school- or hospital-based studies in the early 20th century indicated that cases of trachoma were present across the archipelago, however, no systematic investigation was carried out until a trachoma rapid assessment in 2007. Cases of TF, trachomatous scarring and TT were found in a targeted assessment of high-risk communities in three provinces of the country. In 2012, the International Agency for the Prevention of Blindness commissioned population-based prevalence surveys in five provinces, the results of which indicated a high prevalence of TF in those aged 1–9 years (mean prevalence 18.7%, range 12.0–24.3%) and some cases of TT in those aged 15 years and older (mean prevalence across three provinces 0.1%, range 0.0–0.3%). Data also indicate trachoma endemicity in neighboring Kiribati, Fiji, and Vanuatu. – Prior to the present study, no prevalence data existed for Choiseul, Western, Temotu or Rennell and Bellona provinces of the Solomon Islands, whose combined population comprises approximately a quarter of the nation’s population. Complete geographical survey coverage of the country was needed to understand the burden of trachoma, and the level of priority for intervention. The Global Trachoma Mapping Project (GTMP) aimed to complete the baseline map of trachoma globally in over 30 countries using standardized methodologies, allowing interventions to be directed to those in need. We conducted GTMP-supported surveys to complete the national map of trachoma in the remaining four unmapped provinces of the Solomon Islands.

Materials and methods

The surveys used the GTMP methodology described elsewhere. The four provinces were mapped as three evaluation units (EUs): Choiseul (26,732 inhabitants), Western (76,649), and Rennell and Bellona plus Temotu (24,403). Based on the latest census data, we estimated a mean of 1.47 children aged 1–9 years per household. To see 30 households per village, and achieve a sample size of 1222 children, 1222/(30×1.47) = 27.7 villages should be surveyed. Therefore, we planned to survey 28 clusters per EU. Fieldwork was undertaken from 6 September to 21 November 2013. For each island within an EU, the number of clusters sampled was assigned in proportion to the population of the island. Thereafter, villages were sampled from a standard census list with a probability proportion to size methodology, providing self-weighting of results. On the day of the survey, village leaders were engaged to create a comprehensive list of households, from which 30 households were randomly sampled by drawing lots. All inhabitants of these households who were at least 1 year of age were considered eligible for inclusion. Demographic data were collected from study participants and a standardized examination was conducted by GTMP-certified graders to look for trichiasis, TF and TI. Verbal consent was obtained from the head of the household, from each participating adult, and from parents or guardians on behalf of the children in their care. In addition, verbal assent was obtained from those under 18 years of age. The study was approved by the Solomon Islands National Health Research Ethics Committee and the Ethics Committee of the London School of Hygiene & Tropical Medicine (6319).

Water, sanitation and hygiene (WASH) variables

Recorders were trained to collect household-level WASH variables linked to WHO/UNICEF Joint Monitoring Programme outcomes. Data were collected by carrying out a focused interview with the head of the household using a standard questionnaire and direct observation. Separate questions were asked about sources of water drinking and washing faces; many Pacific Islands households use seawater for personal hygiene purposes.

Statistical analysis

Adjustment of prevalence results was carried out using R 3.0.2 (R Foundation for Statistical Computing, Vienna, Austria ). The overall EU-level adjusted TF prevalence was calculated by adjusting the proportion of children with TF in each cluster in 1-year age groups using 2009 Solomon Islands census data, then determining the mean of all such cluster-level proportions. The same method was used to calculate the overall adjusted trichiasis prevalence, but with adjustment for both sex and age in 5-year age groups. Confidence intervals (CIs) around the prevalence estimates were calculated by bootstrapping the cluster means over 10,000 iterations and taking the 2.5th and 97.5th centiles of all ordered results. Risk factor analysis was carried out in Stata 10.2 (Stata Corp, College Station, TX, USA). A 2-level hierarchical model was used with adjustment for clustering at village and household levels. Univariable associations were considered for inclusion in the multivariable model if p ≤ 0.05 (Wald’s test).

Results

A total of 82 villages were surveyed over three EUs. The coordinates of sampled villages are shown in Figure 1. A total of 2448 households were visited, 9891 inhabitants were eligible to participate in the study, of whom 9224 individuals (93.3%) consented to examination and were examined. Overall, 25 villages were sampled in Choiseul, 25 in Western, and 32 in Rennell-Bellona/Temotu. The number of villages was increased in Rennell-Bellona/Temotu due to low numbers of children found in the villages first sampled. The demographics of those sampled are shown in Table 1.
Figure 1.

Coordinates of villages sampled in the three evaluation units surveyed, Global Trachoma Mapping Project, Solomon Islands, September–November 2013, and trachomatous inflammation – follicular (TF) prevalence estimates in five other provinces. Shapefile source: Global administrative areas (gadm.org).

Table 1.

Sampled population, Global Trachoma Mapping Project, Solomon Islands, September–November 2013.

 Province
 
 ChoiseulWesternRennell-Bellona/TemotuTotal
Sampled, n2709312940539891
Examined, n (%)2634 (97.2)2914 (93.1)3676 (90.7)9224 (93.3)
Absent, n (%)56 (2.1)213 (6.8)340 (8.4)609 (6.2)
Refused, n (%)19 (0.7)2 (0.1)36 (0.9)57 (0.6)
Age, median years (range)17 (1–99)17 (1–95)19 (1–100)18 (1–100)
Female, n (%)1165 (43.0)1458 (46.6)1964 (48.5)4587 (46.3)
Households, n7427519552448
Sampled population, Global Trachoma Mapping Project, Solomon Islands, September–November 2013. Coordinates of villages sampled in the three evaluation units surveyed, Global Trachoma Mapping Project, Solomon Islands, September–November 2013, and trachomatous inflammation – follicular (TF) prevalence estimates in five other provinces. Shapefile source: Global administrative areas (gadm.org). Prevalences of TF in children aged 1–9 years (Figure 2, Table 2) and prevalences of trichiasis in adults (Figure 3, Table 3) are shown by EU. A total of eight cases of trichiasis were found in the survey; six of these cases were found in Western province, and two in Rennell-Bellona/Temotu. The age- and sex-adjusted trichiasis prevalences in those aged 15+ years were 0.0% in Choiseul, 0.16% in Western, and 0.1% in Rennell-Bellona/Temotu.
Figure 2.

Trachomatous inflammation – follicular (TF) prevalence in children aged 1–9 years, Global Trachoma Mapping Project, Solomon Islands, September–November 2013. Shapefile source: Global administrative areas (gadm.org).

Table 2.

Prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years, Global Trachoma Mapping Project, Solomon Islands, September–November 2013.

Evaluation unitExamined, nTF, n (%)Adjusteda TF, % (95% CI)
Choiseul88166 (7.5)6.1 (4.1–8.6)
Western996226 (22.7)20.4 (15.6–26.3)
Rennell-Bellona/Temotu1136296 (26.1)22.0 (18.5–26.0)

aAdjusted by age in 1-year bands.

CI, confidence interval.

Figure 3.

Trichiasis prevalence in those aged 15 years and older, Global Trachoma Mapping Project, Solomon Islands, September–November 2013. Shapefile source: Global administrative areas (gadm.org).

Table 3.

Prevalence of trichiasis in those aged 15 years or older, Global Trachoma Mapping Project, Solomon Islands, September–November 2013.

Evaluation unitExamined, n (%)
Trichiasis, n (%)
Adjusteda trichiasis, % (95% CI)
MaleFemaleMaleFemale
Choiseul533 (36.9)913 (63.1)0 (0.0)0 (0.0)0.0 (0.0–0.2)
Western712 (42.4)967 (57.6)3 (0.4)3 (0.3)0.16 (0.0–0.5)
Rennell-Bellona/Temotu1064 (45.5)1275 (54.5)0 (0.0)2 (0.2)0.04 (0.0–0.3)

aAdjusted for sex and age in 5-year bands.

CI, confidence interval.

Prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years, Global Trachoma Mapping Project, Solomon Islands, September–November 2013. aAdjusted by age in 1-year bands. CI, confidence interval. Prevalence of trichiasis in those aged 15 years or older, Global Trachoma Mapping Project, Solomon Islands, September–November 2013. aAdjusted for sex and age in 5-year bands. CI, confidence interval. Trachomatous inflammation – follicular (TF) prevalence in children aged 1–9 years, Global Trachoma Mapping Project, Solomon Islands, September–November 2013. Shapefile source: Global administrative areas (gadm.org). Trichiasis prevalence in those aged 15 years and older, Global Trachoma Mapping Project, Solomon Islands, September–November 2013. Shapefile source: Global administrative areas (gadm.org).

WASH data

WASH data were obtained from 2448 households. Practicing open defecation was reported by adults in 1443 households (58.9%), with the most common site of defecation being in the sea or on the beach. Only 1006 households (41.1%) reported using some kind of latrine: 302 houses (12.3%) had an improved latrine, of which 260 were private latrines, and 704 (28.8%) households had an unimproved latrine. Overall, 1443 houses (58.9%) had access to improved washing water and 1595 households (65.1%) had improved drinking water. In the univariate logistic regression analysis, no household level WASH variables were associated with the presence of TF in 1–9-year-old children. The full results are shown in Table 4.
Table 4.

Multilevel univariable random effects logistic regression of factors against the outcome of trachomatous inflammation – follicular (TF) in children aged 1–9 years, Global Trachoma Mapping Project, Solomon Islands, September–November 2013.

WASH variableOdds ratio (95% CI)p-value
Use of improved drinking source1.31 (0.96–1.80)0.084
Use of improved washing source1.01 (0.69–1.47)0.972
Household private latrine0.87 (0.54–1.41)0.576
Household improved latrine0.79 (0.50–1.25)0.306
Overall latrine category (open defecation vs unimproved vs improved latrine)0.29
Open defecation1.0 (reference)
Unimproved latrine0.89 (0.71–1.12)
Improved latrine0.76 (0.53–1.11)
Time to get to washing water0.13
All face washing done at water source1.0 (reference)
Water source in the yard0.73 (0.37–1.43)
Less than 30 minutes1.21 (0.62–2.32)
Between 30 minutes and 1 hour0.98 (0.47–2.03)
More than 1 hour1.19 (0.44–3.17)
Time to get to drinking water0.579
Water source in the yard1.0 (reference)
Less than 30 minutes1.28 (0.86–1.90)
Between 30 minutes and 1 hour1.18 (0.70–2.00)
More than 1 hour1.48 (0.77–2.84)

CI, confidence interval.

Multilevel univariable random effects logistic regression of factors against the outcome of trachomatous inflammation – follicular (TF) in children aged 1–9 years, Global Trachoma Mapping Project, Solomon Islands, September–November 2013. CI, confidence interval.

Discussion

The prevalence of active trachoma was above 5% in each EU, and above 10% in two of the three EUs (three of four provinces) studied. WHO guidelines recommend implementation of the A, F and E components of SAFE, including mass administration of azithromycin, in Western and Rennell-Bellona/Temotu provinces, for at least 3 years before impact surveys are done. However, the prevalence of trichiasis in each province was low, and below the level established by WHO as being indicative of a public health problem in all three EUs. This is consistent with the experience of ophthalmologists in the Solomon Islands, who see cases of trichiasis in their clinics very rarely. , This raises the question of whether trachoma can truly be thought to be a significant public health problem in these populations. Trachoma surveys from endemic countries of Sub-Saharan Africa, such as Ethiopia or Nigeria, report much higher prevalences of trichiasis in districts with prevalent TF. It is therefore unclear why, even in the presence of a high prevalence of active trachoma in children, the blinding effects of trachoma are rarely seen in adults in the Solomon Islands. A similar question is raised by corresponding GTMP data from other countries in the South Pacific. The anomaly could be attributable to a different set of C. trachomatis genotypes in the region, a different bacterium altogether being responsible for the active trachoma phenotype, or a more muted scarring response of those infected. – Recent studies on causes of blindness in the Solomon Islands are scarce. Reports from the Fred Hollows Foundation eye health outreach services describe 10 cases of trichiasis identified in the Solomon Islands between 2011 and 2013. These reports suggest cataract is the dominant cause of blindness in the country, and do not suggest a major burden of trachoma. While the clinical snapshot obtained from the current surveys indicates a low prevalence of trachoma’s blinding sequelae, it is not currently clear whether prevalence is changing over time; trachoma could be in a period of increase, stasis or decline. Trachoma has been linked with low levels of access to sanitation. The availability of sanitation found in this study was very low. Adults in a high proportion of households (58.9%) practiced open defecation, yet children from these homes were no more likely to have TF than those from households with the best sanitation access. None of the WASH variables collected were associated with TF in children. This is not too surprising; although the disease is almost exclusively associated with rural areas of poverty and social deprivation, there is some inconsistency in WASH associations and no universal risk factors for trachoma. For example, it has previously been associated with poor access to water, – but clear exceptions exist. – The inhabitants of this diverse group of islands are separated from each other not just geographically, but also culturally and ethnically. It is possible that particular behaviors associated with these cultures could in part explain the differences in trachoma prevalence between EUs, and help to inform appropriate control strategies, but these considerations were not examined in this set of surveys. Based on our results, current WHO guidelines would indicate that azithromycin mass drug administration is needed in all three EUs. Azithromycin distribution would have the added benefit of treating yaws and may also treat urogenital C. trachomatis, both of which are highly prevalent locally. , However, given the paucity of data showing blinding complications of trachoma here, there is also an obligation to undertake intensive basic and operational research into the etiology of, and the effect of SAFE implementation on, the active trachoma phenotype in these populations.
  25 in total

1.  TRACHOMA IN THE BRITISH COLONIAL EMPIRE.-ITS RELATION TO BLINDNESS; THE EXISTING MEANS OF RELIEF; MEANS OF PROPHYLAXIS.

Authors:  A F Maccallan
Journal:  Br J Ophthalmol       Date:  1934-11       Impact factor: 4.638

2.  [Clinical evidence of trachoma in Colombian Amerindians of the Vaupés Province].

Authors:  Hollman Miller; Germán Gallego; Gerzaín Rodríguez
Journal:  Biomedica       Date:  2010 Jul-Sep       Impact factor: 0.935

3.  What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting.

Authors:  Matthew J Burton; Victor H Hu; Patrick Massae; Sarah E Burr; Caroline Chevallier; Isaac A Afwamba; Paul Courtright; Helen A Weiss; David C W Mabey; Robin L Bailey
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

4.  Trachoma in the Pacific Islands: evidence from Trachoma Rapid Assessment.

Authors:  A A Mathew; J E Keeffe; R T Le Mesurier; H R Taylor
Journal:  Br J Ophthalmol       Date:  2009-01-27       Impact factor: 4.638

5.  Eye health outreach services in the Pacific Islands region: an updated profile.

Authors:  Julianna Lees; Judith McCool; Alistair Woodward
Journal:  N Z Med J       Date:  2015-08-21

6.  Population-Based Trachoma Mapping in Six Evaluation Units of Papua New Guinea.

Authors:  Robert Ko; Colin Macleod; David Pahau; Oliver Sokana; Drew Keys; Anthea Burnett; Rebecca Willis; Geoffrey Wabulembo; Jambi Garap; Anthony W Solomon
Journal:  Ophthalmic Epidemiol       Date:  2016-11-28       Impact factor: 1.648

7.  Access to water source, latrine facilities and other risk factors of active trachoma in Ankober, Ethiopia.

Authors:  Ilya Golovaty; Larissa Jones; Bizu Gelaye; Melkie Tilahun; Habtamu Belete; Abera Kumie; Yemane Berhane; Michelle A Williams
Journal:  PLoS One       Date:  2009-08-20       Impact factor: 3.240

Review 8.  Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis.

Authors:  Meredith E Stocks; Stephanie Ogden; Danny Haddad; David G Addiss; Courtney McGuire; Matthew C Freeman
Journal:  PLoS Med       Date:  2014-02-25       Impact factor: 11.069

9.  Zoonotic Chlamydiaceae species associated with trachoma, Nepal.

Authors:  Deborah Dean; James Rothschild; Anke Ruettger; Ram Prasad Kandel; Konrad Sachse
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

10.  Mapping the epidemiology of yaws in the Solomon Islands: a cluster randomized survey.

Authors:  Michael Marks; Ventis Vahi; Oliver Sokana; Elliot Puiahi; Alex Pavluck; Zaixing Zhang; Tenneth Dalipanda; Christian Bottomley; David C Mabey; Anthony W Solomon
Journal:  Am J Trop Med Hyg       Date:  2014-11-24       Impact factor: 2.345

View more
  21 in total

1.  Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji.

Authors:  Naomi Cocks; Merelesita Rainima-Qaniuci; Chelsea Yalen; Colin Macleod; Apisalome Nakolinivalu; Stephanie Migchelsen; Chrissy H Roberts; Robert Butcher; Mike Kama; David Mabey; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-11-16       Impact factor: 2.184

2.  Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.

Authors:  Anaseini Cama; Andreas Müller; Raebwebwe Taoaba; Robert M R Butcher; Iakoba Itibita; Stephanie J Migchelsen; Tokoriri Kiauea; Harry Pickering; Rebecca Willis; Chrissy H Roberts; Ana Bakhtiari; Richard T Le Mesurier; Neal D E Alexander; Diana L Martin; Rabebe Tekeraoi; Anthony W Solomon
Journal:  PLoS Negl Trop Dis       Date:  2017-09-12

3.  Targeted Treatment of Yaws With Household Contact Tracing: How Much Do We Miss?

Authors:  Louise Dyson; Michael Marks; Oliver M Crook; Oliver Sokana; Anthony W Solomon; Alex Bishop; David C W Mabey; T Déirdre Hollingsworth
Journal:  Am J Epidemiol       Date:  2018-04-01       Impact factor: 4.897

4.  Sanitation and water supply coverage thresholds associated with active trachoma: Modeling cross-sectional data from 13 countries.

Authors:  Joshua V Garn; Sophie Boisson; Rebecca Willis; Ana Bakhtiari; Tawfik Al-Khatib; Khaled Amer; Wilfrid Batcho; Paul Courtright; Michael Dejene; Andre Goepogui; Khumbo Kalua; Biruck Kebede; Colin K Macleod; Kouakou IIunga Marie Madeleine; Mariamo Saide Abdala Mbofana; Caleb Mpyet; Jean Ndjemba; Nicholas Olobio; Alexandre L Pavluck; Oliver Sokana; Khamphoua Southisombath; Fasihah Taleo; Anthony W Solomon; Matthew C Freeman
Journal:  PLoS Negl Trop Dis       Date:  2018-01-22

5.  The cost of mapping trachoma: Data from the Global Trachoma Mapping Project.

Authors:  Guillaume Trotignon; Ellen Jones; Thomas Engels; Elena Schmidt; Deborah A McFarland; Colin K Macleod; Khaled Amer; Amadou A Bio; Ana Bakhtiari; Sarah Bovill; Amy H Doherty; Asad Aslam Khan; Mariamo Mbofana; Siobhain McCullagh; Tom Millar; Consity Mwale; Lisa A Rotondo; Angela Weaver; Rebecca Willis; Anthony W Solomon
Journal:  PLoS Negl Trop Dis       Date:  2017-10-18

6.  A systematic review of historical and contemporary evidence of trachoma endemicity in the Pacific Islands.

Authors:  Becca L Handley; Chrissy H Roberts; Robert Butcher
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

7.  Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.

Authors:  Michael Marks; Hilary Toloka; Ciara Baker; Christian Kositz; James Asugeni; Elliot Puiahi; Rowena Asugeni; Kristy Azzopardi; Jason Diau; John M Kaldor; Lucia Romani; Michelle Redman-MacLaren; David MacLaren; Anthony W Solomon; David C W Mabey; Andrew C Steer
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

Review 8.  Strengthening the links between mapping, planning and global engagement for disease elimination: lessons learnt from trachoma.

Authors:  Paul Courtright; Lisa A Rotondo; Chad MacArthur; Iain Jones; Angela Weaver; Biruck Kebede Negash; Nicholas Olobio; Kamal Binnawi; Simon Bush; Mariamo Abdala; Danny Haddad; Astrid Bonfield; Paul Emerson; Virginia Sarah; Anthony W Solomon
Journal:  Br J Ophthalmol       Date:  2018-06-15       Impact factor: 4.638

9.  Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial.

Authors:  Lucia Romani; Michael Marks; Oliver Sokana; Titus Nasi; Bakaai Kamoriki; Handan Wand; Margot J Whitfeld; Daniel Engelman; Anthony W Solomon; Andrew C Steer; John M Kaldor
Journal:  Lancet Glob Health       Date:  2018-10       Impact factor: 38.927

10.  Quality Assurance and Quality Control in the Global Trachoma Mapping Project.

Authors:  Anthony W Solomon; Rebecca Willis; Alexandre L Pavluck; Wondu Alemayehu; Ana Bakhtiari; Sarah Bovill; Brian K Chu; Paul Courtright; Michael Dejene; Philip Downs; Rebecca M Flueckiger; Danny Haddad; P J Hooper; Khumbo Kalua; Biruck Kebede; Amir Bedri Kello; Colin K Macleod; Siobhain McCullagh; Tom Millar; Caleb Mpyet; Jeremiah Ngondi; Benjamin Nwobi; Nicholas Olobio; Uwazoeke Onyebuchi; Lisa A Rotondo; Boubacar Sarr; Oumer Shafi; Oliver Sokana; Sheila K West; Allen Foster
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.